U.S. Automotive Wrap Films Market Growth in the Coming Years

 U.S. Automotive Wrap Films Market Growth & Trends

The U.S. automotive wrap films market size is anticipated to reach USD 4,110.0 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.8% from 2025 to 2030. The growing trend of company spending on automobile advertising and offering sponsorships to the automotive race teams to increase the visibility of the company is expected to drive the demand for automotive wrap films in the U.S.

Companies operating in consumer goods, food and beverages, tourism, electrical and electronics, and various other industries are using vehicles with automotive wraps for showcasing and advertising their product offerings. Companies operating in these industries hire vehicles from fleet owners and use customized wraps with company names and logos imprinted on them. Additionally, an automotive wrap film is a cost-effective solution, which maintains the original paint job and provides a high resale value for the vehicles. The minimum service life for good quality automotive wrap ranges from 5 to 6 years. The rising trend of hydro dipping poses a challenge in the growth of the U.S. market for automotive wrap films.

Automotive wrap films offer the flexibility to get the vehicle fully wrapped or semi-wrapped depending upon the requirement. These wraps can be a bit expensive than paint in the case of complex designs, however, with high quality, the overall return on investment in the case of automotive wrap films is high as compared to vehicle paint. Automotive wraps are a cost-effective option when the paint cost is expected to be very high, for example, in the case of racing cars, as these cars often require quick color and design changes depending upon their sponsors, company, and branding. The low cost of wraps as compared to vehicle paints makes it suitable for these applications, which, in turn, is anticipated to increase the demand over the forecast period.

Prominent players involved in the production of wrap films are focusing on product development and strategic initiatives with regional players to minimize the risk of expanding into a new marketplace. For instance, in October 2020, Arlon Graphics, LLC introduced cast wrap portfolio with FLITE technology. This product innovation enabled the company to cater to vehicle wrap installers with quick and easy installations with fewer rolls for wrapping.

Request a free sample copy or view report summary: U.S. Automotive Wrap Films Market Report

U.S. Automotive Wrap Films Market Report Highlights

• The light-duty vehicles application segment was accounted for over 58.0% of the overall revenue in 2024. This high share is attributed to the rising trend of consumer spending on personalized customization in their vehicles which majorly constitutes lightweight vehicles
• The growing demand for hydro dipping poses a challenge in the growth of automotive wrap films as hydro dipping is a relatively easy and cost-effective solution for customization
• Key players involved in the market are focusing on investment in research and development activities to increase market offerings that give them a competitive edge over the other players
• Exterior location is anticipated to remain the dominant segment in the market for automotive wrap films in the U.S. throughout the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/us-automotive-wrap-films-market-analysis

U.S. Automotive Wrap Films Market Segmentation

Grand View Research has segmented the U.S. automotive wrap films market report based on location and application:

U.S. Automotive Wrap Films Location Outlook (Revenue, USD Million, 2018 - 2030)

• Exterior
• Interior

U.S. Automotive Wrap Films Application Outlook (Revenue, USD Million, 2018 - 2030)

• Heavy-Duty Vehicles
• Medium-Duty Vehicles
• Light-Duty Vehicles

List Of Key Players in the U.S. Automotive Wrap Films Market

• Avery Dennison Corporation
• Arlon Graphics, LLC
• 3M
• KPMF
• Fedrigoni S.P.A.
• Vvivid Vinyl
• ORAFOL Europe GmbH
• Hexis S.A.S.
• JMR Graphics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

China Companion Animal Health Market To Benefit from Increased Global Uptake of 2025 To 2030

 China Companion Animal Health Market Growth & Trends

The China companion animal health market size is anticipated to reach USD 2.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.22% from 2025 to 2030. The key factors driving the market growth include rising initiatives by key market players, a growing pet population, and high usage of e-commerce channels.

The COVID-19 pandemic had a significant impact on the market in 2020. The adverse effects of the pandemic include supply chain bottlenecks, decreased sales & marketing initiatives, and dampened demand. However, pet ownership and expenditure continued to rise in the country during 2020. Even during the pandemic, online sales of the pet industry showed accelerated growth after an initial slump, as reported by China Daily. Key factors identified for this growth include increasing per capita GDP and pet humanization. For instance, according to the World Bank estimates, per capita GDP in China, in 2020, was USD 10,500, notably greater than the per capita GDP of USD 8,066 in 2015 and USD 4,550 in 2010.

The rising pet population in China is a key factor driving the market growth. The RADII Media reported that in 2020, the popularity of cats as pets was growing rapidly across China. The main reason identified for this trend was cats being relatively low-maintenance pets as compared to pet dogs. As per the Shanghai United Media Group, the preference for exotic and other companion animals is increasing among the young population in the country. Key factors fueling this growth include certain pets needing less upkeep as compared to dogs or horses. For example, geckos or small mammals require much less space, energy, and time from the pet owner as compared to mainstream pets.

Increasing usage of online channels for purchasing pet products is anticipated to propel the market in the coming years. China Daily reported that in 2019, online sales of the pet industry crossed 30 billion Yuan, or about USD 4.3 billion. 70% of the total sales were accounted for by e-commerce giants, such as Tmall and Taobao, as reported at Pet Fair Asia 2020. Key market players leveraged this opportunity to strengthen their market presence. In February 2019, Boehringer Ingelheim, for instance, launched the first-of-its-kind flagship store by a multinational animal health company on Tmall for pet parasiticides. The store was launched to provide customers with a reliable and convenient online purchasing channel for the company’s full range of pet parasiticides.

Request a free sample copy or view report summary: China Companion Animal Health Market Report

China Companion Animal Health Market Report Highlights

• The companion animal medicine segment accounted for the highest share of the market in 2024 owing to the increased awareness about pet health and the high prevalence of diseases in pets
• Dogs represented the largest segment by animal type for both companion animal medicine as well as diagnostics markets in 2020
• By indication, non-infectious diseases dominated the China pet medicine as well as diagnostics markets in 2024
• The growth can be credited to the high awareness about animal health & diseases and increased pet expenditure & pet humanization
• Global trends, such as the One Health initiative, are expected to further propel awareness about animal health and boost the demand for medicines and diagnostics products for pets
• In June 2020, the World Bank Group approved a loan of USD 300 million to help strengthen select national and provincial systems in China to lower the risk of zoonoses and other emerging health threats as part of the Emerging Infectious Diseases Prevention, Preparedness and Response Project

Access Press Release@ https://www.grandviewresearch.com/press-release/china-companion-animal-health-market-analysis

China Companion Animal Health Market Segmentation

Grand View Research has segmented the China companion animal health market on the basis of type, animal type, product, indication, and diagnosis method:

China Companion Animal Health Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Dogs
• Cats
• Equine
• Others

China Companion Animal Health Product Outlook (Revenue, USD Million, 2018 - 2030)

• Biologics
  • Vaccines
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
  • Other Biologics
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Supplements
• Diagnostics
• Others

China Companion Animal Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail
• E-commerce
• Hospital/ Clinic Pharmacies

China Companion Animal Health End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals & Clinics
• Point-of-Care
• Others

List Of Key Players in the China Companion Animal Health Market

• Boehringer Ingelheim International GmbH
• Elanco
• Merck & Co., Inc.
• Zoetis
• Ceva
• Virbac
• Bimeda, Inc.
• IDEXX Laboratories
• Thermo Fisher Scientific
• Randox Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antiarrhythmic Drugs Market to Reflect Robust Expansion During 2025-2030: Grand View Research Inc.

 Antiarrhythmic Drugs Market Growth & Trends

The global antiarrhythmic drugs market size is expected to reach USD 1.6 billion in 2030 and is projected to grow at a CAGR of 6.35% from 2025 to 2030. This anticipated growth is driven by multiple interrelated factors, including the rising prevalence of cardiovascular diseases (CVDs), an aging global population, advancements in drug development, regulatory support, and government initiatives aimed at improving cardiovascular health.According to the World Health Organization (WHO), CVDs are the leading cause of death globally, responsible for approximately 17.9 million deaths annually.

Furthermore, the aging population is a significant factor contributing to market expansion. The U.S. Census Bureau reports that by 2030, approximately 20% of the U.S. population will be 65 years or older. This demographic shift is expected to lead to an increase in cardiovascular conditions, including arrhythmias, thereby heightening the demand for antiarrhythmic drugs. As people age, their risk of developing heart conditions increases, necessitating ongoing treatment and management strategies. This trend is not limited to the U.S.; many developed and developing nations are experiencing similar demographic changes, resulting in a global increase in demand for antiarrhythmic therapies.

Recent advancements in drug development are further propelling market growth. Research and innovation in the field of antiarrhythmic drugs have led to the introduction of novel compounds and therapeutic approaches. For instance, the development of new drug formulations that target specific ion channels has improved the efficacy and safety profiles of these medications. Moreover, advances in personalized medicine and pharmacogenomics are paving the way for tailored treatment strategies that optimize drug efficacy based on individual patient profiles. Such innovations not only enhance treatment outcomes but also encourage the adoption of antiarrhythmic therapies among healthcare providers.

Request a free sample copy or view report summary: Antiarrhythmic Drugs Market Report

Antiarrhythmic Drugs Market Report Highlights

• By drug class, the beta blockers segment accounted for the largest revenue share of 34.80% in 2024. Their efficacy in reducing heart rate and controlling blood pressure has made them a cornerstone in the treatment of these disorders.
• Based on route of administration, the oral segment accounted for the largest revenue share of around 71.0% in 2024. Oral formulations allow patients to self-administer treatments at home, eliminating the need for invasive procedures or hospital visits, which can be particularly appealing in managing chronic conditions such as atrial fibrillation and ventricular tachycardia.
• Based on distribution channels, the hospital pharmacies segment accounted for the largest revenue share of around 60.53% in global market for antiarrhythmic drugs in 2024.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antiarrhythmic-drugs-market

Antiarrhythmic Drugs Market Segmentation

Grand View Research has segmented the global antiarrhythmic drugs market report based on drug class, route of administration, distribution channel, and region:

Antiarrhythmic Drugs Class Outlook (Revenue, USD Million, 2018 - 2030)

• Sodium Channel Blockers
• Beta Blockers
• Potassium Channel Blockers
• Calcium Channel Blockers
• Other

Antiarrhythmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Parenteral
• Other

Antiarrhythmic Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail Pharmacies
• Other

Antiarrhythmic Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Antiarrhythmic Drugs Market

• Pfizer
• Novartis
• Mylan (now part of Viatris)
• Baxter International
• Sanofi
• GlaxoSmithKline
• Mayne Pharma
• Upsher-Smith Laboratories
• Amomed Pharma
• Merck

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. General Anesthesia Drugs Market to Exhibit Impressive Growth During 2025 – 2030: Grand View Research Inc.

 U.S. General Anesthesia Drugs Market Growth & Trends

The U.S. general anesthesia drugs market size is projected to reach USD 2.03 billion by 2030, and is anticipated to grow at a CAGR of 2.82% from 2025 to 2030, according to Grand View Research, Inc. The rising number of surgical procedures primarily drives this growth. The American Society of Anesthesiologists (ASA) highlights a consistent increase in surgeries, attributed to an aging population, the growing prevalence of chronic diseases, and advancements in surgical techniques. The CDC reported in February 2024 that approximately 129 million Americans have at least one major chronic disease, such as cancer, heart disease, diabetes, and hypertension. This high prevalence of chronic conditions necessitates numerous cardiovascular and other surgeries, which in turn drives the demand for effective general anesthesia drugs.

Advancements in anesthesia technology are another critical driver. Innovations such as ultra-short-acting anesthetics, like remifentanil, offer improved control over anesthesia depth and faster recovery times, enhancing patient outcomes and driving market growth. Additionally, the development of advanced delivery systems and monitoring technologies, including automated anesthesia delivery systems, has revolutionized anesthesia practices by improving precision and safety.

Regulatory developments also play a significant role. The FDA's expedited approval pathways for breakthrough therapies facilitate quicker access to new and effective anesthetics. For instance, the recent approval of ZYNRELEFTM, a novel extended-release anesthetic, illustrates how regulatory advancements support the introduction of innovative products.

Request a free sample copy or view report summary: U.S. General Anesthesia Drugs Market Report

U.S. General Anesthesia Drugs Market Report Highlights

• Based on drug, the propofol segment dominated the market with a substantial revenue share of 25.52% in 2024 and is also expected to grow at the fastest CAGR during the forecast period, driven by its widespread use as a preferred agent for induction and maintenance of general anesthesia.
• Based on route of administration, the intravenous segment held the largest revenue share in 2024 and is also expected to grow at the fastest CAGR of 3.03% during the forecast period
• Based on application, the knee and hip replacements segment dominated the market, capturing a substantial revenue share.
• Based on end-use, the hospitals segment dominated the market, capturing a substantial revenue share of 67.05% in 2024. Hospitals are the primary settings for major surgeries and complex medical procedures that require general anesthesia.

Access Press Release@ https://www.grandviewresearch.com/press-release/us-general-anesthesia-drugs-market-analysis

U.S. General Anesthesia Drugs Market Segmentation

Grand View Research has segmented the U.S. general anesthesia drugs market report based on drug, route of administration, application, end-use and region:

U.S. General Anesthesia Drug Outlook (Revenue, USD Million, 2018 - 2030)

• Sevoflurane
• Propofol
• Dexmedetomidine
• Remifentanil
• Desflurane
• Midazolam
• Others - (Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental, etc.)

U.S. General Anesthesia Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Intravenous
• Inhaled

U.S. General Anesthesia End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Others 

U.S. General Anesthesia Application Outlook (Revenue, USD Million, 2018 - 2030)

• Heart Surgeries
• Cancer
• General Surgery
• Knee and hip replacements
• Others

List of Key Players in the U.S. General Anesthesia Drugs Market

• Baxter International Inc.
• AstraZeneca
• AbbVie Inc.
• Braun Melsungen AG
• Fresenius SE & Co. KgaA
• Pfizer
• Hospira Inc.
• Aspen Pharmacare Holdings Limited
• Hikama Pharmaceuticals plc
• Abbott Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Air Purifier Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 U.S. Air Purifier Market Growth & Trends

The U.S. air purifier market size is expected to reach USD 6,823.4 million by 2030, registering a CAGR of 7.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The harmful effects of air pollution on human health have led to an increase in demand for air purifiers in the U.S. As people become more aware of the impact of air pollution on their health, they are taking steps to mitigate its effects by investing in air purifiers for their homes and offices. With the rise in air pollution levels in many parts of the U.S., the demand for air purifiers is expected to continue to increase in the coming years.

With the regulations and standards set by the federal government about air quality maintenance, there has been a growing demand for air purifiers in the U.S. The Environmental Protection Agency (EPA) has set strict standards for air quality, and many states have their regulations as well. For instance, the U.S. Occupational Safety and Health Administration has set some standards related to ventilation and air contaminants. Such standards are likely to drive the demand for air purifiers in the U.S.

Furthermore, as individuals and families allocate increased resources toward improving their quality of life and ensuring a healthy living environment, the demand for air purifiers is expected to surge in the coming years. According to data published by the Organization for Economic Cooperation and Development (OECD), total household spending has been rising in the U.S. and will reach 15,902.6 billion in 2021. Thus, an increase in household spending is anticipated to contribute to the adoption of air purifiers in the coming years.

The ongoing urbanization and changing housing trends have led to the rising demand for air purifiers. As a large number of people reside in densely populated areas with high levels of air pollution, the requirement for effective air purification becomes paramount. Moreover, the shift toward small living spaces, such as apartments and condominiums, increases the importance of compact and efficient air purifiers.

Technological advancements have further played a significant role in driving the demand for air purifiers. The modern air purifiers available in the market come equipped with advanced features such as HEPA filters, activated carbon filters, and UV-C light technology. Moreover, the key market players are integrating IoT-based technologies with air purifiers, which allow users to control the device remotely through their smartphones or voice assistants. With such advanced features, air purifiers have become more efficient, user-friendly, and convenient to use, thereby driving their demand in the market.

Daikin Industries, Ltd., Honeywell International, Inc., LG Electronics, Panasonic Corporation, and IQAir Group are major players in the U.S. market. Strategies adopted by these companies usually include expansion of their market reach by undertaking partnerships and collaborations, mergers & acquisitions, and new product launches. For instance, in January 2023, Panasonic Corporation introduced the nanoe X portable in-vehicle air cleaner, catering to the North American markets, aimed at enhancing and safeguarding cabin air purity. This innovative air purifier not only effectively diminishes odors but also works to inhibit viruses, bacteria, mold, and allergens, both in the air and on surfaces within the vehicle cabin.

In January 2024, COWAY CO., LTD. introduced the Airmega 100 air purifier, expanding its range of best-in-class products for cleaner air in the U.S. market. This latest addition marks Airmega's debut cylindrical model and is offered at Coway's most affordable price point ever, making it an accessible option for smaller spaces.

Request a free sample copy or view report summary: U.S. Air Purifier Market Report

U.S. Air Purifier Market Report Highlights

• The activated carbon segment is anticipated to witness the highest growth over the forecast period, owing to its ability to absorb gases and odors emanating from cooking, mold, chemicals, pets, and smoke.
• The online segment is anticipated to witness the highest CAGR over the forecast period, as more and more consumers choose to purchase air purifiers through e-commerce platforms.
• Standalone or portable air purifiers are designed to filter air and remove airborne particles, such as bacteria, viruses, and dust particles.
• The below 250 Sq. Ft. segment is anticipated to witness the highest growth over the forecast period. These air purifiers are portable, compact, and lightweight, making them easy to move from room to room as needed.
• The commercial segment is anticipated to witness the highest growth over the forecast period. Air purifiers have witnessed a significant surge in adoption within commercial applications, driven by a growing awareness of indoor air quality and its impact on the health and well-being of occupants.

Access Press Release@ https://www.grandviewresearch.com/press-release/us-air-purifier-market-analysis

U.S. Air Purifier Market Segmentation

Grand View Research has segmented U.S. air purifier market report based on technology, sales channel, type, coverage range, application, and region.:

U.S. Air Purifier Technology Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030)

• High Efficiency Particulate Air (HEPA)Activated Carbon
• Ionic Filters
• Electrostatic Precipitator
• Others

U.S. Air Purifier Sales Channel Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030)

• Online
• Offline
  • Hypermarkets/Supermarkets
  • Retail Stores
  • Specialty Stores
  • Others

U.S. Air Purifier Type Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030

• Standalone/Portable
• In-duct/Fixed

U.S. Air Purifier Coverage Range Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030)

• Below 250 Sq. Ft.
• 250-400 Sq. Ft.
• 401-700 Sq. Ft.
• Above 700 Sq. Ft.

U.S. Air Purifier Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030)

• Commercial
  • Retail Shops (Mercantile)
  • Offices
  • Healthcare Facilities
  • Hospitality
  • Schools & Educational Institutions
  • Laboratories
  • Transport
  • Others
• Residential
• Industrial

U.S. Air Purifier Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2018 - 2030)

• Alabama
• Alaska
• Arizona
• Arkansas
• California
• Colorado
• Connecticut
• Delaware
• Florida
• Georgia
• Hawaii
• Idaho
• Illinois
• Indiana
• Iowa
• Kansas
• Kentucky
• Louisiana
• Maine
• Maryland
• Massachusetts
• Michigan
• Minnesota
• Mississippi
• Missouri
• Montana
• Nebraska
• Nevada
• New Hampshire
• New Jersey
• New Mexico
• New York
• North Carolina
• North Dakota
• Ohio
• Oklahoma
• Oregon
• Pennsylvania
• Rhode Island
• South Carolina
• South Dakota
• Tennessee
• Texas
• Utah
• Vermont
• Virginia
• Washington
• West Virginia
• Wisconsin
• Wyoming

List of Key Players of U.S. Air Purifier Market

• Daikin Industries, Ltd.
• Sharp Electronics Corporation
• Honeywell International, Inc.
• Panasonic Corporation
• AprilAire
• LG Electronics
• Koninklijke Philips N.V.
• Samsung Electronics Co., Ltd.
• Unilever (Blueair)
• Dyson
• Hamilton Beach Brands, Inc.
• SharkNinja
• Lasko Products, LLC (Germ Guardian)
• Vesync Co., Ltd (Arovast Corporation)
• COWAY CO., LTD.
• PuroAir
• IQAir Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Diabetes Management Market Factors, Rising Demand, Driving Growth by 2030

 Digital Diabetes Management Market Growth & Trends

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, registering a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI). 

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes. 

The market growth is further augmented by the increasing prevalence of obesity, the growing aging population, and increasing awareness regarding diabetes preventive care. Moreover, the market is driven by the increasing number of active users of smart devices and the launch of new apps that allow patients to monitor their blood glucose. These apps use advanced technology for health care professionals and provide patients with better health outcomes. In May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of the next-generation BGM system. This is expected to propel the demand for the product, thereby driving the overall market in the country. 

Request a free sample copy or view report summary: Digital Diabetes Management Market Report

Digital Diabetes Management Market Report Highlights

• The continuous glucose monitoring systems segment dominated the market by capturing a share of 40.4% in 2024. CGM systems offer real-time glucose tracking, providing critical insights for both Type 1 and Type 2 diabetes management.
• The wearable devices segment held the largest market share in 2024 and is also expected to grow at the fastest CAGR of 8.9% over the forecast period, driven by the increasing demand for convenience, continuous monitoring, and real-time data tracking.
• The hospital segment dominated the market by capturing a share of 41.5% in 2024. Hospitals remain the primary setting for diagnostic testing, advanced treatments, and monitoring for patients with severe or complex diabetes.
• North America digital diabetes management market held the largest share of 38.2% in 2024. This dominance is driven by the presence of leading market players in the region and the increasing prevalence of diabetes.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-digital-diabetes-management-market

Digital Diabetes Management Market Segmentation 

Grand View Research has segmented the global digital diabetes management market on the basis of on product, type, end-use and region:

Digital Diabetes Management Product Outlook (Revenue, USD Million, 2018 - 2030)

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps/Closed Loop Systems
• Apps
  • Digital Diabetes Management Apps
  • Weight & Diet Management Apps

Digital Diabetes Management Type Outlook (Revenue, USD Million, 2018 - 2030)

• Wearable Devices
• Handheld Devices

Digital Diabetes Management End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Home settings
• Diagnostic centers

Digital Diabetes Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE 
  • Kuwait

List of Key Players in the Digital Diabetes Management Market

• Abbott
• Medtronic
• Hoffmann-La Roche Ltd.
• Bayer AG
• Sanofi
• Dexcom, Inc.
• LifeScan, Inc.
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG
• Braun Melsungen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

General Anesthesia Drugs Market Report | Business Growth 2030

 General Anesthesia Drugs Market Growth & Trends

The global general anesthesia drugs market size is projected to reach USD 6.56 billion by 2030, and projected to grow at a CAGR of 3.68% from 2025 to 2030, according to a new report by Grand View Research, Inc. This projected growth is driven by several critical factors, including increasing surgical volumes, advancements in anesthesia technology, rising prevalence of chronic diseases, and supportive government initiatives. The World Health Organization (WHO) estimates that the volume of surgeries is increasing due to greater access to healthcare and the growing number of elective and emergency procedures. In 2022 alone, there were nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally, highlighting the surge in surgical interventions required. This increase in surgical activity is fueling a heightened demand for general anesthesia, as it is crucial for ensuring patient safety and comfort during operations.

Government initiatives to expand healthcare access and improve infrastructure further support market growth. In many regions, including North America and Europe, healthcare reforms and funding are increasing the availability of surgical services and improving the quality of care. For instance, the U.S. Affordable Care Act and similar initiatives in other countries are expanding surgery access, contributing to the higher demand for general anesthesia drugs. Investments in healthcare infrastructure and new healthcare facilities enhance the anesthesia market.

Technological advancements in anesthesia play a significant role in market growth. Innovations such as target-controlled infusion systems, new anesthetic agents with improved safety profiles, and enhanced monitoring technologies contribute to the efficiency and effectiveness of anesthesia. For instance, developing anesthetics with faster onset and recovery times improves patient outcomes and drives demand.

Request a free sample copy or view report summary: General Anesthesia Drugs Market Report

General Anesthesia Drugs Market Report Highlights

• In 2024, the propofol segment dominated the market with a substantial share of 25.52% and is also expected to grow at the fastest CAGR during the forecast period. Propofol is renowned for its rapid onset and quick recovery times, which enhance patient comfort and procedural efficiency.
• The intravenous (IV) segment held the largest revenue share in 2024 and is also expected to grow at the fastest CAGR of 3.9% during the forecast period.
• In 2024, the knee and hip replacements segment dominated the market, capturing a substantial revenue share. This dominance is driven by the increasing prevalence of osteoarthritis, advancements in surgical techniques, and demographic trends.
• In 2024, the hospitals segment dominated the market, capturing a substantial revenue share of 67.05%.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-general-anesthesia-drugs-market

General Anesthesia Drugs Market Segmentation

Grand View Research has segmented the global general anesthesia drugs market based on drug, route of administration, application, end-use, and region:

General Anesthesia Drug Outlook (Revenue, USD Million, 2018 - 2030)

• Sevoflurane
• Propofol
• Dexmedetomidine
• Remifentanil
• Desflurane
• Midazolam
• Others - (Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental, etc.)

General Anesthesia Drugs Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Intravenous
• Inhaled

General Anesthesia Drugs End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Others 

General Anesthesia Drugs Application Outlook (Revenue, USD Million, 2018 - 2030)

• Heart Surgeries
• Cancer
• General Surgery
• Knee And Hip Replacements
• Others

General Anesthesia Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the General Anesthesia Drugs Market

• Baxter International Inc.
• AstraZeneca
• AbbVie Inc.
• Braun Melsungen AG
• Fresenius SE & Co. KgaA
• Pfizer
• Hospira Inc.
• Aspen Pharmacare Holdings Limited
• Hikama Pharmaceuticals plc
• Abbott Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Digital Imaging System Market Is Expected To Accomplish A Valuation Of Around $6.56 Billion By 2030: Grand View Research Inc.

 Medical Digital Imaging System Market Growth & Trends

The global medical digital imaging system market size is expected to reach USD 51.7 billion by 2030, registering a CAGR of 6.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing demand for advanced imaging solutions with minimal errors and faster results is likely to drive the market during the forecast period. Expanding applications of medical digital imaging in preventive healthcare is poised to contribute to the growth of the market.

Some of the causes of chronic diseases are unhealthy diets, sedentary lifestyles, tobacco and alcohol consumption, and biological factors including dyslipidemia, hypertension, obesity, and hyperinsulinemia. The rising prevalence of various chronic diseases is projected to augment the medical digital imaging market during the forecast period.

Governments of countries such as the U.S., U.K., India, and Canada are undertaking initiatives to boost the market. These initiatives are in various forms such as declining import duties for devices, providing favorable policies, and educating physicians & medical imaging device operators. The demand for diagnostic techniques has been increasing in the past few years owing to technological advancements in the field of diagnostics and rising awareness among people regarding the early diagnosis of diseases.

Request a free sample copy or view report summary: Medical Digital Imaging System Market Report

Medical Digital Imaging System Market Report Highlights

• The hardware system segment dominated the market in 2024 by capturing a share of 60.8%. This segment is further divided into workstations, servers, and storage systems.
• The diagnostic imaging segment dominated the market and accounted for the largest revenue share of 59.2% in 2024; this segment is expected to grow at the fastest CAGR over the forecast period.
• The hospitals segment held the largest revenue share of 51.8% in 2024. Hospitals are key adopters of advanced medical digital imaging systems due to their need for comprehensive diagnostic and therapeutic capabilities.
• The diagnostic imaging segment dominated the market and accounted for the largest revenue share of 59.2% in 2024; this segment is expected to grow at the fastest CAGR over the forecast period.
• Regional & service portfolio expansions and mergers & acquisitions are among the key strategies adopted by these players to gain a higher market share.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-digital-imaging-systems-market

Medical Digital Imaging System Market Segmentation

Grand View Research has segmented the global medical digital imaging system market report based on component, modality, deployment mode, application, end use, and region:

Medical Digital Imaging System Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware
  • Workstations
  • Servers
  • Storage Systems
• Software
  • Picture Archiving and Communication Systems (PACS)
  • Radiology Information Systems (RIS)
  • Vendor Neutral Archives (VNA)
  • Advanced Visualization Software
  • AI/ML-based Tools for Image Analysis
• Services

Medical Digital Imaging System Modality Outlook (Revenue, USD Million, 2018 - 2030)

• X-ray
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Nuclear Imaging (PET/SPECT)
• Mammography

Medical Digital Imaging System Deployment Mode Outlook (Revenue, USD Million, 2018 - 2030)

• On-Premises
• Cloud-Based
• Hybrid

Medical Digital Imaging System Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic Imaging
• Therapeutic Imaging
• Research and Training

Medical Digital Imaging System End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Diagnostic Imaging Centers
• Other End Use

Medical Digital Imaging SystemRegional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Medical Digital Imaging System Market

• GE Healthcare
• Koninklijke Philips N.V.
• Siemens Healthineers
• Canon Medical Systems Corporation
• Mindray Medical International
• FUJIFILM VisualSonics Inc.
• Carestream Health
• Hitachi
• Samsung Medison Co., Ltd.
• Koning Corporation
• Agfa-Gevaert Group
• MIM Software, Inc.
• DeepHealth
• Epic Systems Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Sterilization Market is Expected to Amplify $2.69 Billion Value by 2030: Grand View Research Inc.

 Dental Sterilization Market Growth & Trends

The global dental sterilization market size is expected to reach USD 2.69 billion by 2030, expanding at a CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of dental conditions, growing number of dental care personnel, and rising number of dental facilities are anticipated to drive the market.

Rising number of dental surgical procedures and increasing efforts to infection control and prevent cross-infection by instruments are stimulating the growth of the market. Market players are also continuously involved in introducing new products, which is expected to positively influence the growth of the market. For instance, the introduction of AdvantaClear surface disinfectant by Hu-Friedy, which kills pathogens in one-minute.

Key players operating in the market are using different strategies such as new product development, acquisitions, partnerships, joint ventures, and agreements to strengthen their foothold in the market space.

Moreover, the dental sterilization market in developed economies, such as U.S., Germany, France, and Australia, is comparatively mature owing to the domicile of several key market players belonging to these countries and high demand for such products among end users.

On the other hand, developing Asian and Latin American countries, currently, have a moderate adoption of these products. Economic growth and rising disposable income in these countries are likely to propel the market. Manufacturing companies are investing in these rapidly developing markets in order to tap into the potential, provided pricing and distribution activities are undertaken efficiently.

Request a free sample copy or view report summary: Dental Sterilization Market Report

Dental Sterilization Market Report Highlights

• The instruments segment led the market with the largest revenue share of 73.3% in 2024 and is expected to grow at the fastest CAGR from 2025 to 2030, These products are often disposed of after single use, which makes their life cycle short and frequency of purchase high.
• Based on end use, the dental clinics segment led the market with the largest revenue share of 67.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period
• North America dominated the dental sterilization market with the largest revenue share of 43.8% in 2024

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-sterilization-market

Dental Sterilization Market Segmentation

Grand View Research has segmented the global dental sterilization market report based on the product, end use, and region

Dental Sterilization Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments
  • Sterilization Equipment
    • High-temperature Sterilizers
    • Low- temperature Sterilizers
  • Cleaning and Disinfectant Equipment
    • Washer Disinfectants
    • Ultrasonic Cleaners
  • Packaging Equipment
• Consumables and Accessories
  • Sterilization Packaging Accessories
  • Instrument Disinfectants
  • Surface Disinfectants
  • Sterilization Indicators
  • Lubrication and Cleaning Solutions

Dental Sterilization End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Dental Clinics
• Dental Laboratories

Dental Sterilization Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Dental Sterilization Market

• Hu-Friedy Mfg. Co., LLC.
• Dentsply Sirona
• Midmark Corporation
• MATACHANA
• W&H Dentalwerk
• Nakanishi inc.
• SciCan Ltd.
• Getinge
• Tuttnauer U.S.A. Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Single-use Pump Market to Partake Significant Development During 2025 to 2030: Grand View Research Inc.

 Single-use Pump Market Growth & Trends

The global single-use pump market size is expected to reach USD 995.2 million by 2030 and is expected to grow at a CAGR of 13.23% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is mainly driven by the various benefit it offers over conventional pumps. These include cost-effectiveness, improved sterility & contamination control, process efficiency due to reduction in installation and changeover time, and regulatory compliance, etc.Pumps are utilized in the biopharmaceutical sector to transport fluids, such as buffers and media, through tubing to process equipment. The disposable pump is a vital part of the single-utilization technology sector.

These single-use pump chambers significantly reduce the cost incurred in cleaning and sterilization of equipment in conventional pump systems. It also eliminates the risk of cross-batch contamination. As a result of increased flexibility and reduced batch timings, single-use pumps are expected to rise rapidly in the near future.The market has shown substantial growth over the last few years owing to increased biopharma product manufacturing in various established and emerging nations along with other benefits associated with single-use systems, such as scalability and adaptability. Furthermore, the majority of biopharmaceutical operations, such as mammalian cell culture, utilize single-use technology, both upstream and downstream, thus driving market growth.

Furthermore, the increasing adoption of single-use systems for manufacturing diverse modalities, such as monoclonal antibodies, conventional vaccines, and mRNA-based vaccines, in developing countries ultimately fueled global product demand. According to the International AIDS Vaccine Initiative (IAVI), eight monoclonal antibody production facilities were operating in Argentina, Brazil, China, India, Japan, and Singapore in 2019, with another five under construction in these countries. These developments will create a demand for single-use pumps and further boost market growth. In addition, due to the rising adoption of single-use systems in the biopharma industry and expanding biopharma contract development and manufacturing organizations, single-use pumps are likely to be in high demand during the projection period.

Request a free sample copy or view report summary: Single-use Pump Market Report

Single-use Pump Market Report Highlights

• The equipment product segment accounted for the largest share in 2024. The market is expanding due to the growing demand for biologics and rising demand for single-use pumps among end-users
• The Polypropylene (PP) pumps segment accounted for the largest share in 2024. It is widely used in the biopharmaceutical business because it is resistant to a wide range of solutions, is leachable, and can be utilized at high temperatures
• The biopharmaceutical & pharmaceutical companies end-use segment accounted for the largest share in 2024. The biopharma businesses have turned their focus to contract production and development facilities, which anticipates a positive impact on product demand
• North America held the largest share in 2024. This is mostly due to the presence of major industry participants, the development of advanced single-use pumps, and the adoption of regulatory-compliant products in the bioprocessing industry in the region 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-single-use-pump-market

Single-use Pump Market Segmentation

Grand View Research Inc. has segmented the global single-use pump market report based on product, material, end use, and region:

Single-use Pump Product Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment
  • Peristaltic pumps
  • Quaternary diaphragm pump
  • Centrifugal pumps
  • Others
• Accessories

Single-use Pump Material Outlook (Revenue, USD Million, 2018 - 2030)

• Polypropylene (PP) Pumps
• Polyethylene (PE) Pumps
• Others

Single-use Pump End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes
• Others

Single-use Pump Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Single-use Pump Market

• Dover Corporation
• Spirax Group plc
• Xylem
• Levitronix
• Stobbe Group
• Getinge (High Purity New England)
• Ace Sanitary
• Verder Group (Verder Liquids)
• Sartorius AG
• Avantor Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. OTC Glucose Biosensors Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 U.S. OTC Glucose Biosensors Market Trends

The U.S. over-the-counter glucose biosensors market size was estimated at USD 105.3 million in 2024 and is anticipated to exhibit a CAGR of 11.5% from 2025 to 2030. This growth is attributed to the increasing prevalence of diabetes and prediabetes, the shift towards preventive healthcare, and the increased adoption of glucose biosensors by athletes are some of the major factors driving market growth. Moreover, the aging population of the country further contributes to this growth as this age group is significantly vulnerable to chronic diseases such as diabetes, which increases the demand for effective solutions such as glucose biosensors.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the U.S. over-the-counter (OTC) glucose biosensors industry. Obesity is a major factor leading to diabetes. According to CBS News published in September 2024, approximately 30% of adults were classified as obese, with a body mass index (BMI) of 30 or higher in 2020. Furthermore, the CDC reported an increase in the adult obesity rate to 41.9% by 2020. Currently, based on survey data from 2021 to 2023, the CDC estimates that 40.3% of adults are obese. In addition to obesity, diabetes is becoming increasingly prevalent globally. The International Diabetes Federation (IDF) estimates that there were 537 million adults (aged 20-79) living with diabetes in 2021, and this number is expected to increase to 642 million by 2040. The IDF also reports that the prevalence of diabetes is growing globally, with the highest increase witnessed in low- and middle-income countries.

In the U.S., diabetes is a widespread health issue affecting millions of people. According to the CDC, as of 2024, 11.6% of the entire U.S. population-about 38.4 million people of all ages-has been diagnosed with diabetes. The percentage of adults aged 18 or older is even higher, with 14.7% or 38.1 million people affected. Around 8.7 million adults with diabetes were unaware of their condition or did not report it, representing 22.8% of all adults with diabetes and 3.4% of all U.S. adults. The risk of diabetes increases with age, with the percentage of adults with diabetes peaking at 29.2% among those aged 65 or above. These statistics highlight the significant impact that diabetes has on the U.S. population.

Access Research Report@ https://www.grandviewresearch.com/industry-analysis/us-over-the-counter-glucose-biosensors-market-report

Moreover, the shift towards preventive healthcare is also contributing to the growth of the U.S. over-the-counter (OTC) glucose biosensors industry. Consumers increasingly prioritize health management to avoid chronic diseases such as diabetes, driven by rising awareness, government initiatives, and technological advancements. Preventive healthcare emphasizes early detection and continuous monitoring, fueling demand for accessible and user-friendly glucose monitoring devices.

OTC glucose biosensors such as Stelo and Lingo provide individuals with convenient, non-prescription options to monitor blood glucose levels at home. These devices offer ease of use with compact designs and seamless smartphone integration for real-time tracking and data analysis. Stelo and Lingo support proactive health management, enabling users to detect early changes in their glucose levels and take timely action, promoting a preventive approach to diabetes care.

Key U.S. Over-the-Counter Glucose Biosensors Company Insights

Some key providers in the industry are DexCom, Inc., and Abbott. These pioneering companies offer OTC glucose biosensors and have leveraged their technological expertise to establish a foothold in this emerging market. Both companies focus on affordability, ease of use, and accessibility. The increasing consumer awareness and adoption of biosensor technology are expected to intensify the competitive rivalry between the market players.

Key U.S. Over-the-Counter Glucose Biosensors Companies:

• DexCom, Inc.
• Abbott

Recent Developments

• In June 2024, Abbottreceived FDA clearance for its two new over-the-counter continuous glucose monitoring systems, Libre Rio and Lingo. Lingo targets consumers seeking to improve their health, while Libre Rio is designed for people aged 18 years and above with Type 2 diabetes who don't use insulin. Both systems leverage Abbott's advanced FreeStyle Libre technology to enhance glucose management and overall wellness.
• In March 2024, Dexcomreceived FDA clearance for Stelo, the first OTC glucose biosensor, for adults with Type 2 diabetes not using insulin. This innovation enhances access to continuous glucose monitoring technology in the country.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.